Ovariectomy and 17beta-estradiol replacement do not alter beta-amyloid levels in sheep brain.

The benefits of estrogen replacement as a preventative treatment for Alzheimer's disease (AD) are subject to debate. Because the effects of estrogen depletion and replacement on accumulation of the neurotoxic beta-amyloid (A beta) peptide in transgenic animal models of AD have been variable, we examined A beta levels and oxidative stress in a nontransgenic animal model. Sheep have traditionally been used as a model for human reproduction; however because they share 100% sequence homology with the human form of A beta, they may also have potential as a nontransgenic model for A beta biology. The effect of ovariectomy and estrogen replacement administered for 6 months via slow-release implant was examined in the brain of 4.5-yr-old sheep. A beta levels were measured by ELISA, and protein levels of the amyloid precursor protein (APP), APP C-terminal fragments (C100), and presenilin-1 were examined semiquantitatively by Western blot as markers of APP processing. Markers of oxidative stress were examined semiquantitatively by Western blot [4-hydroxy-2(E)-nonenal] and oxyblot (protein carbonyls). We found no effects of estrogen depletion and supplementation in terms of AD-related biochemical markers, including A beta levels, APP processing, and oxidative stress levels. Evidence of a trend toward increased P450 side-chain cleavage enzyme levels in the hippocampus of ovariectomized and estrogen supplemented sheep suggests that neurosteroidogenesis may compensate for gonadal estrogen depletion; however, these findings cannot explain the lack of effect of estrogen supplementation on APP processing. It is possible that supraphysiological doses of estrogen are necessary to yield antiamyloidogenic and antioxidative benefits in ovariectomized sheep.

[1]  R. Mayeux,et al.  Sex hormone binding globulin and incident Alzheimer’s disease in elderly men and women , 2010, Neurobiology of Aging.

[2]  P. Hoyer,et al.  Behavioral consequences of ovarian atrophy and estrogen replacement in the APPswe mouse , 2008, Neurobiology of Aging.

[3]  K. Koike,et al.  Enhanced activity of hippocampal BACE1 in a mouse model of postmenopausal memory deficits , 2008, Neuroscience Letters.

[4]  Frank Z. Stanczyk,et al.  Progesterone and Estrogen Regulate Alzheimer-Like Neuropathology in Female 3xTg-AD Mice , 2007, The Journal of Neuroscience.

[5]  A. Harvey,et al.  Oxidative stress in a rat model of chronic gliosis , 2007, Neurobiology of Aging.

[6]  N. Hunter.  Scrapie: uncertainties, biology and molecular approaches. , 2007, Biochimica et biophysica acta.

[7]  R. Martins,et al.  Reproductive hormones modulate oxidative stress in Alzheimer's disease. , 2006, Antioxidants & redox signaling.

[8]  R. Mayeux,et al.  Bioavailable estradiol and age at onset of Alzheimer's disease in postmenopausal women with Down syndrome , 2006, Neuroscience Letters.

[9]  V. W. Henderson,et al.  Estrogen-containing hormone therapy and Alzheimer’s disease risk: Understanding discrepant inferences from observational and experimental research , 2006, Neuroscience.

[10]  Rena Li,et al.  Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer's disease animal model. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[11]  R. Appleyard,et al.  Ovariectomy alters the structural and biomechanical properties of ovine femoro-tibial articular cartilage and increases cartilage iNOS. , 2005, Osteoarthritis and cartilage.

[12]  S. Paul,et al.  Estrogen therapy fails to alter amyloid deposition in the PDAPP model of Alzheimer's disease. , 2005, Endocrinology.

[13]  R. Martins,et al.  The role of beta amyloid in Alzheimer's disease: still a cause of everything or the only one who got caught? , 2004, Pharmacological research.

[14]  JoAnn E Manson,et al.  Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. , 2004, JAMA.

[15]  R. Martins,et al.  Baculoviruses expressing the human familial Alzheimer's disease presenilin 1 mutation lacking exon 9 increase levels of an amyloid beta-like protein in Sf9 cells , 2004, Molecular Psychiatry.

[16]  R. Martins,et al.  Luteinizing Hormone, a Reproductive Regulator That Modulates the Processing of Amyloid-β Precursor Protein and Amyloid-β Deposition* , 2004, Journal of Biological Chemistry.

[17]  R. B. Johnson,et al.  The ovariectomized sheep as a model for human bone loss. , 2004, Journal of comparative pathology.

[18]  H. Tanila,et al.  Estrogen treatment improves spatial learning in APP + PS1 mice but does not affect beta amyloid accumulation and plaque formation , 2004, Experimental Neurology.

[19]  A. Maggi,et al.  Estrogens in the nervous system: mechanisms and nonreproductive functions. , 2004, Annual review of physiology.

[20]  R. Mayeux,et al.  Elevated sex-hormone binding globulin in elderly women with Alzheimer’s disease , 2004, Neurobiology of Aging.

[21]  C. Mallinckrodt,et al.  Central and peripheral temperature changes in sheep following ovariectomy. , 2003, Maturitas.

[22]  Jonathan D. Smith,et al.  Safe and effective method for chronic 17beta-estradiol administration to mice. , 2003, Contemporary topics in laboratory animal science.

[23]  Christopher J. Brown,et al.  Impact mechanics and axonal injury in a sheep model. , 2003, Journal of neurotrauma.

[24]  Robert B Wallace,et al.  Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. , 2003, JAMA.

[25]  Brenda L Plassman,et al.  Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. , 2002, JAMA.

[26]  Jonathan D. Smith,et al.  Ovariectomy of young mutant amyloid precursor protein transgenic mice leads to increased mortality , 2002, Journal of Molecular Neuroscience.

[27]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[28]  J. Lafrancois,et al.  Modulation of Aβ peptides by estrogen in mouse models , 2002, Journal of neurochemistry.

[29]  S. Mellon,et al.  Biosynthesis and action of neurosteroids , 2001, Brain Research Reviews.

[30]  A. Harvey,et al.  Altered expression of apolipoprotein E, amyloid precursor protein and presenilin-1 is associated with chronic reactive gliosis in rat cortical tissue , 2001, Neuroscience.

[31]  A. Maggi,et al.  Engineering of a mouse for the in vivo profiling of estrogen receptor activity. , 2001, Molecular endocrinology.

[32]  S. Gandy,et al.  Ovariectomy and 17β-estradiol modulate the levels of Alzheimer's amyloid β peptides in brain , 2000, Experimental Gerontology.

[33]  S. Gandy,et al.  Ovariectomy and 17β-estradiol modulate the levels of Alzheimer’s amyloid β peptides in brain , 2000, Neurology.

[34]  C. Mallinckrodt,et al.  The effect of raloxifene on coronary arteries in aged ovariectomized ewes. , 2000, Journal of veterinary pharmacology and therapeutics.

[35]  K. Hall,et al.  The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis. , 1998, Archives of general psychiatry.

[36]  L. Amaducci,et al.  Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging , 1998, Neurology.

[37]  N. Ishiguro,et al.  Characterization of the sheep apolipoprotein E (ApoE) gene and allelic variations of the ApoE gene in scrapie Suffolk sheep. , 1998, Gene.

[38]  H. Wiśniewski,et al.  Increased plasma amyloid β protein 1–42 levels in Down syndrome , 1998, Neuroscience Letters.

[39]  H. Jansen,et al.  The GnRH System of Seasonal Breeders: Anatomy and Plasticity , 1997, Brain Research Bulletin.

[40]  N. Gales,et al.  Evidence for a prolonged postimplantation period in the Australian sea lion (Neophoca cinerea). , 1997, Journal of reproduction and fertility.

[41]  R. Brookmeyer,et al.  A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease , 1997, Neurology.

[42]  M. Sanders,et al.  Level of nutrition modulates the dynamics of oestradiol feedback on plasma FSH in ovariectomized ewes. , 1997, Animal reproduction science.

[43]  Yaakov Stern,et al.  Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease , 1996, The Lancet.

[44]  C. Saper,et al.  Injections of okadaic acid, but not beta-amyloid peptide, induce Alz-50 immunoreactive dystrophic neurites in the cerebral cortex of sheep , 1996, Neuroscience Letters.

[45]  C. Saper,et al.  Ultrastructure of neurofibrillary tangles in the cerebral cortex of sheep , 1995, Neurobiology of Aging.

[46]  J. Buckwalter,et al.  Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects. , 1994, Archives of neurology.

[47]  G. Martin,et al.  Effects of nutrition on testicular size and the concentrations of gonadotrophins, testosterone and inhibin in plasma of mature male sheep. , 1994, Journal of reproduction and fertility.

[48]  H. Braak,et al.  Abnormally phosphorylated tau protein related to the formation of neurofibrillary tangles and neuropil threads in the cerebral cortex of sheep and goat , 1994, Neuroscience Letters.

[49]  C. Saper,et al.  Neurofibrillary tangles in the cerebral cortex of sheep , 1994, Neuroscience Letters.

[50]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[51]  C. Saper,et al.  Alz-50 immunohistochemistry in the normal sheep striatum: a light and electron microscope study , 1993, Brain Research.

[52]  K. Roby,et al.  Generation and characterization of antipeptide antibodies to rat cytochrome P-450 side-chain cleavage enzyme , 1991, Molecular and Cellular Endocrinology.

[53]  E. Baulieu,et al.  Pregnenolone and its sulfate ester in the rat brain , 1983, Brain Research.

[54]  E. Baulieu,et al.  Characterization and measurement of dehydroepiandrosterone sulfate in rat brain. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[55]  D. Lindsay,et al.  INCREASED PLASMA LH LEVELS IN SEASONALLY ANOVULAR MERINO EWES FOLLOWING THE INTRODUCTION OF RAMS , 1980 .

[56]  Caroline Lee,et al.  Development of a maze test and its application to assess spatial learning and memory in Merino sheep , 2006 .

[57]  S. Schmidt,et al.  ELISA Method for Measurement of Amyloid-ß Levels , 2005 .

[58]  Einar M. Sigurdsson,et al.  Amyloid proteins : methods and protocols , 2005 .

[59]  Jonathan D. Smith,et al.  17α-estradiol and 17β-estradiol treatments are effective in lowering cerebral amyloid-β levels in AβPPSWE transgenic mice , 2002 .

[60]  H. Wiśniewski,et al.  Plasma and cerebrospinal fluid Levels of amyloid β proteins 1-40 and 1-42 in Alzheimer disease , 2000 .

[61]  R. Martins,et al.  Decreased secretion of amyloid precursor protein in Chinese hamster ovary cells overexpressing presenilin 1 , 1999 .

[62]  H. Esterbauer,et al.  Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.